THE FAILURE OF ANTICOAGULANT THERAPY TO PREVENT MYOCARDIAL INFARCTION IN PATIENTS WITH PREMONITORY SYMPTOMS OF AN IMPENDING CORONARY OCCLUSION
Authors: M SCHLACHMAN
Journal: Annals of Internal Medicine (1957)

Article1 April 1957THE FAILURE OF ANTICOAGULANT THERAPY TO PREVENT MYOCARDIAL INFARCTION IN PATIENTS WITH PREMONITORY SYMPTOMS OF AN IMPENDING CORONARY OCCLUSIONMILTON SCHLACHMAN, M.D., F.A.C.P.MILTON SCHLACHMAN, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-46-4-728 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe advent of the anticoagulants in the treatment of coronary occlusion was received with almost universal enthusiasm when the reports of Nichol, Wright and Peters appeared in the medical literature.1-8 However, the intervening years have somewhat modified in the minds of many physicians the original acceptance of the value of anticoagulants, and reports have appeared which raise some doubt as to their usefulness in this condition.9-15Nevertheless, many leaders in the field of anticoagulant therapy still retain their original faith in these drugs, and they have implied that the use of anticoagulants in patients with impending coronary occlusion or with...Bibliography1. NicholPage ESSW: Dicumarol therapy in acute coronary thrombosis: results in fifty attacks, J. Florida M. A. 32: 365-370, 1946. MedlineGoogle Scholar2. Wright IS: Experience with Dicumarol in the treatment of coronary thrombosis, Proc. Am. Federation Clin. Research 2: 101-102, 1945. MedlineGoogle Scholar3. Wright IS: Experience with Dicumarol (3,3′ methylene-bis-(4-hydroxycoumarin)) in the treatment of coronary thrombosis with myocardial infarction, Am. Heart J. 32: 20-31, 1946. CrossrefMedlineGoogle Scholar4. PetersGuytherBrambel HRJRCE: Dicumarol in acute coronary thrombosis, J. A. M. A. 130: 398-403, 1946. CrossrefMedlineGoogle Scholar5. PetersDoengesBrambel HRJPCE: Further experiences with Dicumarol therapy in coronary thrombosis, South. M. J. 41: 526-535, 1948. CrossrefMedlineGoogle Scholar6. WrightMarpleBeck ISCDDF: Report on the Committee for Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction, Am. Heart J. 36: 801-815, 1948. CrossrefMedlineGoogle Scholar7. Nichols ES: Treatment of acute coronary thrombosis with Dicumarol: further observations, Am. Heart J. 33: 722-723, 1947. Google Scholar8. WrightMarpleBeck ISCDDF: Anticoagulant therapy of coronary thrombosis, J. A. M. A. 38: 1074-1079, 1948. CrossrefGoogle Scholar9. BairHeineKrasnoff SWISO: The mortality of acute myocardial infarction in private practice, Am. J. M. Sc. 222: 500-505, 1951. CrossrefMedlineGoogle Scholar10. Schnur S: Mortality and other studies questioning the evidence for and value of routine anticoagulant therapy in acute myocardial infarction, Circulation 7: 855-868, 1953. CrossrefMedlineGoogle Scholar11. Schnur S: Mortality rates in acute myocardial infarction. 1. The "normal" yearly variation, and the effect of hospital admission policy, Ann. Int. Med. 39: 1014-1017, 1953. LinkGoogle Scholar12. RussekZohman HIBL: Selection of patients for anticoagulant therapy in acute myocardial infarction, Am. J. M. Sc. 288: 133-139, 1954. CrossrefGoogle Scholar13. Schnur S: The current dispute concerning anticoagulants in acute myocardial infarction, J. A. M. A. 156: 1127-1130, 1954. CrossrefMedlineGoogle Scholar14. RussekZohman HIBL: "Selective" versus routine use of anticoagulants in acute myocardial infarction, J. A. M. A. 156: 1131-1132, 1954. Google Scholar15. Garb S: The current status of anticoagulants in the treatment of myocardial infarction, Am. J. M. Sc. 229: 534-548, 1955. CrossrefMedlineGoogle Scholar16. NicholFassett ESDW: An attempt to forestall acute coronary thrombosis: preliminary note on the continuous use of Dicumarol, South. M. J. 40: 631-637, 1947. CrossrefMedlineGoogle Scholar17. AllenHinesKvaleBarker EVEAWFNW: The use of Dicumarol as an anticoagulant: experience in 2,307 cases, Ann. Int. Med. 27: 371-381, 1947. LinkGoogle Scholar18. SuzmanRuskinGoldberg NMHDB: An evaluation of the effect of continuous long term anticoagulant therapy in the prognosis of myocardial infarction: a report of 82 cases, Circulation 12: 338-352, 1955. CrossrefMedlineGoogle Scholar19. WrightFoley ISWT: Anticoagulants in heart disease, Am. J. Med. 3: 718-739, 1947. CrossrefMedlineGoogle Scholar20. KyesDrakeJonesSmith JWEHTNFJ: Survival rates after myocardial infarction with and without long term anticoagulant therapy, Am. J. M. Sc. 226: 607-610, 1953. CrossrefMedlineGoogle Scholar21. NicholBorg ESJF: Long term Dicumarol therapy to prevent recurrent coronary artery thrombosis, Circulation 1: 1097-1104, 1950. CrossrefMedlineGoogle Scholar22. WrightBourgainFoleyMcDevittGrossBurkeSimonLibermanSymonsHuebner ISRWTECGEJCR: Long term anticoagulant therapy, Circulation 9: 748-757, 1954. CrossrefMedlineGoogle Scholar23. Thompson WP: The prevention of coronary thrombosis, M. Clin. North America 36: 991-999, 1952. CrossrefGoogle Scholar24. Nichol ES: Long term anticoagulant therapy in coronary atherosclerosis: a cooperative study, 2nd World Congress of Cardiology, Washington, D. C., 1954. Google Scholar25. Engelberg H: Simplified heparin therapy of impending and acute myocardial infarction, Ann. Int. Med. 44: 466-475, 1956. LinkGoogle Scholar26. SmithPapp KSC: The prevention of impending cardiac infarction by anticoagulant treatment, Brit. Heart J. 13: 467-474, 1951. CrossrefMedlineGoogle Scholar27. SoldantBest DYCH: Heparin and coronary thrombosis in experimental animals, Lancet 2: 130-132, 1938. Google Scholar28. SoldantNissimBest DYRCH: Production and prevention of cardiac mural thrombosis in dogs, Lancet 2: 592-595, 1939. Google Scholar29. DaleJaques DVLB: The prevention of experimental thrombosis by dicumarin, Canad. M. A. J. 46: 541-548, 1942. Google Scholar30. CrafoordJorpes CE: Heparin as a prophylactic against thrombosis, J. A. M. A. 116: 2831-2835, 1941. CrossrefGoogle Scholar31. Bauer G: Heparin therapy in acute deep vein thrombosis, J. A. M. A. 131: 196-203, 1946. CrossrefMedlineGoogle Scholar32. Jorpes JE: The origin and physiology of heparin: the specific therapy in thrombosis, Ann. Int. Med. 27: 361-370, 1947. LinkGoogle Scholar33. Zilliacus H: On the specific treatment of thrombosis and pulmonary embolism, Acta med. Scandinav. Supp. 171: 187, 1946. Google Scholar34. StatsNeuhof DH: Concentrated aqueous heparin, Am. J. M. Sc. 214: 159-162, 1947. CrossrefMedlineGoogle Scholar35. Walker J: The efficacy of heparin administered by intravenous, intramuscular and subcutaneous routes and a study of the effect of five bacteriostatic agents on heparin action, Surgery 17: 54-60, 1945. Google Scholar36. LeeWhite RLPD: A clinical study of the coagulation time of blood, Am. J. M. Sc. 145: 495-503, 1913. CrossrefGoogle Scholar37. Patterson JC: Vascularization and hemorrhage of the intima of arteriosclerotic coronary arteries, Arch. Path. 22: 313-324, 1936. Google Scholar38. Patterson JC: Capillary rupture with intimal hemorrhage as a causative factor in coronary thrombosis, Arch. Path. 25: 474-487, 1938. Google Scholar39. Wartman WB: Occlusion of the coronary arteries by hemorrhage into their walls, Am. Heart J. 15: 459-470, 1938. CrossrefGoogle Scholar40. Patterson JC: Relation of physical exertion and emotion to precipitation of coronary thrombosis, J. A. M. A. 112: 895-897, 1939. CrossrefGoogle Scholar41. HornFinkelstein JL: Arteriosclerosis of the coronary arteries and the mechanism of their occlusion, Am. Heart J. 19: 655-682, 1940. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Elmhurst, Long Island, N. Y.*Received for publication July 19, 1956.From the New York Medical College, Metropolitan Medical Center, New York, N. Y.Requests for reprints should be addressed to Milton Schlachman, M.D., 89-25 Elmhurst Avenue, Elmhurst, Long Island, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDie Klinik der nicht-transmuralen Infarkte der HerzvorderwandSecond Thoughts on Anticoagulant Treatment for Coronary Disease 1 April 1957Volume 46, Issue 4Page: 728-735KeywordsAnticoagulant therapyAnticoagulantsDrug therapyElectrocardiographyHemorrhageMyocardial infarctionThrombosis ePublished: 1 December 2008 Issue Published: 1 April 1957 PDF downloadLoading ...